2,394 results match your criteria Journal of Oncology Practice[Journal]


Looking Through the Lens of a Family Planner to Prioritize Reproductive Health Among Women With Cancer.

J Oncol Pract 2019 Feb 17;15(2):e141-e152. Epub 2018 Dec 17.

1 John H. Stroger, Jr Hospital of Cook County, Chicago, IL.

Purpose:: Prioritization of cancer treatment initiation in women of reproductive age may underscore potential implications on reproductive health. This study describes a family planning quotient (FPQ) and reproductive life index (RepLI) tool designed to help providers to discuss effectively reproductive health with women with cancer.

Methods:: We tailored the FPQ/RepLI tool for patients with cancer after development in the family planning setting and piloted it with 36 oncology patients referred to our family planning clinic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00429DOI Listing
February 2019

Consecutive Emergence of Typical Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in a Patient With Metastatic Pulmonary Squamous Cell Carcinoma.

J Oncol Pract 2019 Feb;15(2):115-118

1 National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Republic of China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00536DOI Listing
February 2019

Managing Drug Interactions With Oral Anticancer Agents: Signals, Noise, and Echoes.

Authors:
R Donald Harvey

J Oncol Pract 2019 Feb;15(2):91-92

1 Emory University School of Medicine and Winship Cancer Institute of Emory University, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00721DOI Listing
February 2019

Palbociclib-Induced Posterior Reversible Encephalopathy Syndrome: A Previously Unreported Toxicity.

J Oncol Pract 2019 Feb;15(2):119-121

Mater Misericordiae University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00643DOI Listing
February 2019

Acute Lymphoblastic Leukemia in the Older Adult.

J Oncol Pract 2019 Feb;15(2):67-75

1 Gehr Family Leukemia Research Center, City of Hope National Medical Center, Duarte, CA.

Acute lymphoblastic leukemia (ALL) in older adults presents a real challenge as a result of adverse disease biology and comorbidities that preclude delivering curative regimens. Conventional chemotherapy approaches have generally yielded unsatisfactory results in older patients with ALL as a result of excessive induction mortality, chemotherapy resistance of the leukemia, and the need to omit or dose reduce key drugs during the course of therapy because of adverse effects. Philadelphia chromosome-positive ALL represents about a quarter of newly diagnosed older adults, and the striking single-agent activity and excellent safety profile of tyrosine kinase inhibitors has allowed incorporation of these agents into therapy, significantly improving the outcome of older adults with Philadelphia chromosome-positive ALL. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00271DOI Listing
February 2019

Oral Anticancer Therapy: Management of Drug Interactions.

J Oncol Pract 2019 Feb;15(2):81-90

5 Allegheny Health Network, Pittsburgh, PA.

Oral anticancer therapy is increasingly integrated into the care of patients with cancer. Recognition and management of drug-drug interactions (DDIs) is critical to providing efficacious and safe anticancer treatment. DDIs with QTc-prolonging agents, anticoagulants, enzyme inducers and inhibitors, antidepressants, and acid suppressants are commonly encountered with anticancer therapies. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00483DOI Listing
February 2019

Interpreting Oncology Care Model Data to Drive Value-Based Care: A Prostate Cancer Analysis.

J Oncol Pract 2019 Feb 11:JOP1800336. Epub 2019 Feb 11.

2 Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.

Purpose:: The Oncology Care Model (OCM) must be clinically relevant, accurate, and comprehensible to drive value-based care.

Methods:: We studied OCM data detailing observed and expected expenses for 6-month-long episodes of care for patients with prostate cancer. We constructed seven disease state-treatment dyads into which we grouped each episode on the bases of diagnoses, procedures, and medications in OCM claims data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00336DOI Listing
February 2019
1 Read

Identifying Potentially Avoidable Hospitalizations in Medicare Patients With Prostate Cancer: A Retrospective Analysis.

J Oncol Pract 2019 Feb 11:JOP1800560. Epub 2019 Feb 11.

3 Rutgers-Cancer Institute of New Jersey, New Brunswick, NJ.

Purpose:: If identifiable, potentially avoidable hospitalizations (PAHs) can serve as an important target for cost containment efforts in oncology.

Methods:: PAHs among a cohort of Medicare patients with prostate cancer were identified using a two-stage consensus-driven review process. In stage 1, two clinicians independently evaluated admissions records using a case review form, which we modified from a previous study to assess for PAHs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00560DOI Listing
February 2019

Evaluating the Impact of Treatment Care Planning on Quality Measures.

J Oncol Pract 2019 Jan 31:JOP1800390. Epub 2019 Jan 31.

9 University of South Alabama Mitchell Cancer Institute, Mobile, AL.

Purpose:: The Center for Medicare & Medicaid Innovation Oncology Care Model (OCM) requires documentation of a 13-point Institute of Medicine care management plan for Medicare patients. In addition, OCM includes evaluation of quality using key performance measures that align with the ASCO Quality Oncology Practice Initiative (QOPI). Both efforts are designed to improve patient-centered care and foster patients' engagement in their care plan. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00390
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00390DOI Listing
January 2019
8 Reads

Challenges Associated With Living Remotely From a Pediatric Cancer Center: A Qualitative Study.

J Oncol Pract 2019 Jan 31:JOP1800115. Epub 2019 Jan 31.

3 Washington University in St Louis, St Louis, MO.

Purpose:: Pediatric patients with cancer who live in rural communities face disparate access to medical services compared with those in urban areas. Our objectives were to use qualitative methods to describe how living in a rural setting during receipt of treatment at an urban cancer center affects a patient's clinical course and to identify feasible areas of intervention to enhance service to these families.

Materials And Methods:: We conducted semistructured interviews of caregivers of pediatric patients with cancer who received treatment at an urban pediatric hospital in the Midwest. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00115
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00115DOI Listing
January 2019
2 Reads

"A Tool, Not a Crutch": Patient Perspectives About IBM Watson for Oncology Trained by Memorial Sloan Kettering.

J Oncol Pract 2019 Jan 28:JOP1800417. Epub 2019 Jan 28.

1 Memorial Sloan Kettering Cancer Center; and Weill Cornell Medical College, New York, NY.

Purpose:: IBM Watson for Oncology trained by Memorial Sloan Kettering (WFO) is a clinical decision support tool designed to assist physicians in choosing therapies for patients with cancer. Although substantial technical and clinical expertise has guided the development of WFO, patients' perspectives of this technology have not been examined. To facilitate the optimal delivery and implementation of this tool, we solicited patients' perceptions and preferences about WFO. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00417DOI Listing
January 2019
1 Read

Performance of a Hospital Pathway for Patients With a New Single Brain Mass.

J Oncol Pract 2019 Jan 25:JOP1700098. Epub 2019 Jan 25.

Massachusetts General Hospital and Harvard Medical School, Boston, MA.

Purpose:: To reduce care variation and improve the management of patients with newly identified single brain masses and no history of cancer, we implemented a dedicated admission protocol.

Methods:: We reviewed records of 206 patients who presented to our emergency department between January 2010 and May 2016 with a new single brain mass but no history of cancer. Patients admitted before the protocol implementation were designated the pre-implementation group (PRE), and those admitted after implementation were designated the post-implementation group (POST). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.17.00098DOI Listing
January 2019
4 Reads

Decreasing Inappropriate Use of Rasburicase to Promote Cost-Effective Care.

J Oncol Pract 2019 Feb 23;15(2):e178-e186. Epub 2019 Jan 23.

1 University of Texas Southwestern Medical Center, Dallas, TX.

Background:: Rasburicase is a recommended treatment of tumor lysis syndrome and patients at high-risk for developing tumor lysis syndrome. Unfortunately, it is expensive, and unnecessary use raises costs of care.

Methods:: Plan, Do, Study, Act methodology was used to decrease the inappropriate use of rasburicase. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00528DOI Listing
February 2019

ASCO Standards for Safe Handling of Hazardous Drugs.

J Oncol Pract 2019 Feb 22;15(2):65-66. Epub 2019 Jan 22.

3 Michiana Hematology Oncology, Mishawaka, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00701DOI Listing
February 2019
1 Read

The Cost of Cure: Barriers to Access for Hepatitis C Virus Treatment in South Texas.

J Oncol Pract 2019 Feb 22;15(2):61-63. Epub 2019 Jan 22.

School of Public Health, University of Texas Health Science Center at Houston, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00525DOI Listing
February 2019

Errata.

Authors:

J Oncol Pract 2019 Jan;15(1):60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00737DOI Listing
January 2019

Not All That Slurs Is Stroke: A Case of Chemotherapy-Induced Leukoencephalopathy.

J Oncol Pract 2019 Jan;15(1):55-57

1 Brooke Army Medical Center, San Antonio, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00604
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00604DOI Listing
January 2019
1 Read

Errata.

Authors:

J Oncol Pract 2019 Jan;15(1):60

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00736DOI Listing
January 2019

A New Frontier for Evidence-Informed Integrative Oncology Care.

Authors:
Gabriel Lopez

J Oncol Pract 2019 Jan;15(1):15-16

1 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00745
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00745DOI Listing
January 2019
5 Reads

Implementing Integrative Oncology: Hopes and Challenges.

J Oncol Pract 2019 Jan;15(1):17-18

2 Seattle Cancer Alliance, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00755DOI Listing
January 2019

Optimal Management of Neutropenic Fever in Patients With Cancer.

J Oncol Pract 2019 Jan;15(1):19-24

1 University of Nebraska Medical Center, Omaha, NE.

Febrile neutropenia remains an important complication of treatment with cytotoxic chemotherapy. It is often the first and sometimes the only sign or symptom of infection in this vulnerable patient population. Urgent and appropriate evaluation and treatment are imperative because delay in initiating appropriate antibiotic therapy may be life threatening. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00269DOI Listing
January 2019
1 Read

Putting Integrative Oncology Into Practice: Concepts and Approaches.

J Oncol Pract 2019 Jan;15(1):7-14

1 Memorial Sloan Kettering Cancer Center, New York, NY.

Unmet symptom needs and a desire for holistic health approaches or even cure are among the motivations patients have for seeking out complementary and alternative medicine. Using complementary and alternative medicine instead of conventional cancer treatment can have a negative impact on clinical outcomes and survival. Integrative oncology is a patient-centered, evidence-informed field of comprehensive cancer care that uses mind-body practices, natural products, and lifestyle modifications from different traditions alongside conventional cancer treatments. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00554
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00554DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333385PMC
January 2019
9 Reads

Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine.

J Oncol Pract 2019 Jan;15(1):44-49

7 University of Washington Medical Center, Seattle, WA.

Oncologists face ethical challenges when patients use potentially harmful complementary and alternative medicine in addition to or instead of conventional treatments for their cancer. For example, a patient may forego effective cancer treatment in favor of alternative therapies and suffer significant harm as a result. Similarly, false beliefs about the efficacy of complementary therapies may complicate the process of shared decision making about cancer treatment. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00432DOI Listing
January 2019

Febrile Neutropenia: An Ounce of Prevention or a Pound of Cure.

Authors:
Gary H Lyman

J Oncol Pract 2019 Jan;15(1):27-29

1 Fred Hutchinson Cancer Research Center; University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00750DOI Listing
January 2019
1 Read

Piloting a Financial Counseling Intervention for Patients With Cancer Receiving Chemotherapy.

J Oncol Pract 2019 Jan 9:JOP1800270. Epub 2019 Jan 9.

1 Northwestern University, Chicago, IL.

Purpose:: National organizations encourage communication about costs of cancer care; however, few data are available on health system models for identifying and assisting patients with financial distress (FD). We report the feasibility and acceptability of a financial counseling (FC) intervention for patients who receive chemotherapy at a comprehensive cancer center.

Materials And Methods:: Patients were randomly assigned 1:1 to FC or standard care. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00270DOI Listing
January 2019

Safe Handling of Hazardous Drugs: ASCO Standards Summary.

J Oncol Pract 2019 Feb 9;15(2):112-114. Epub 2019 Jan 9.

3 Michiana Hematology Oncology, Mishiwaka, IN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00659DOI Listing
February 2019

Impact of Peer Review on Use of Hypofractionated Regimens for Early-Stage Breast Cancer for Patients at a Tertiary Care Academic Medical Center and Its Community-Based Affiliates.

J Oncol Pract 2019 Feb 9;15(2):e153-e161. Epub 2019 Jan 9.

1 University of Kansas School of Medicine, Kansas City, KS.

Purpose:: Data have demonstrated that hypofractionated radiation therapy (HFRT) and conventionally fractionated radiation therapy regimens are equivalent with respect to outcomes. Efforts to increase HFRT use have had mixed success. We implemented a prospective peer review chart rounds integrating all practice sites and reviewed the use of HFRT in an attempt to identify potential predictors of use. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00190DOI Listing
February 2019
4 Reads

Impact of Accuracy of Survival Predictions on Quality of End-of-Life Care Among Patients With Metastatic Cancer Who Receive Radiation Therapy.

J Oncol Pract 2019 Jan 8:JOP1800516. Epub 2019 Jan 8.

Stanford Cancer Institute, Stanford, CA.

Purpose:: For patients treated with palliative radiation, we examined the association between life expectancy predictions by radiation oncologists and aggressive end-of-life care.

Materials And Methods:: We included decedents from a study that assessed the ability of oncologists to predict survival of patients with metastatic cancer who received radiation. We identified patients who died within 12 months of study enrollment to assess accuracy of predictions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00516DOI Listing
January 2019

Advanced Practice Providers and Survivorship Care: They Can Deliver.

J Oncol Pract 2019 Jan 7:JOP1800359. Epub 2019 Jan 7.

Memorial Sloan Kettering Cancer Center, New York, NY; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands; and Duke Cancer Institute, Durham, NC.

Introduction:: As the number of cancer survivors grows, new models of survivorship care are being implemented, but there is limited evaluation to date. This retrospective review assesses the concordance of care provided to adult-onset cancer survivors by advanced practice providers (nurse practitioners and physician assistants) with Institute of Medicine guidelines for survivorship care.

Methods:: Records from three survivorship clinics at a single institution were reviewed for frequency of recurrence surveillance, screening for second cancers, symptom management (physical, psychological), health promotion education (alcohol, tobacco, cholesterol, and bone density screenings; diet/exercise discussion), care coordination, and provision of care plan. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00359
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00359DOI Listing
January 2019
4 Reads

Improving Timeliness of Oncology Assessment and Cancer Treatment Through Implementation of a Multidisciplinary Lung Cancer Clinic.

J Oncol Pract 2019 Feb 7;15(2):e169-e177. Epub 2019 Jan 7.

1 Queen's University, Kingston, Ontario, Canada.

Purpose:: Timely lung cancer care has been associated with improved clinical outcomes and patient satisfaction. We identified improvement opportunities in lung cancer management pathways at Kingston Health Sciences Centre. Quality improvement strategies led to the implementation of a multidisciplinary lung cancer clinic (MDC). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00214DOI Listing
February 2019

Continuous Quality Improvement Measured With Time-Driven Activity-Based Costing in an Outpatient Cancer Surgery Center.

J Oncol Pract 2019 Feb 7;15(2):e162-e168. Epub 2019 Jan 7.

1 The University of Texas MD Anderson Cancer Center, Houston, TX.

Purpose:: As health care costs rise, continuous quality improvement and increased efficiency are crucial to reduce costs while providing high-quality care. Time-driven activity-based costing (TDABC) can help identify inefficiencies in processes of cancer care delivery. This study measured the process performance of Port-a-Cath placement in an outpatient cancer surgery center by using TDABC to evaluate patient care process. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00394
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00394DOI Listing
February 2019
2 Reads

Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary.

J Oncol Pract 2019 Feb 27;15(2):108-111. Epub 2018 Dec 27.

3 Cleveland Clinic-Taussig Cancer Center, Cleveland, OH.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00629
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00629DOI Listing
February 2019
2 Reads

Reducing Cancer Costs Through Symptom Management and Triage Pathways.

J Oncol Pract 2019 Feb 21;15(2):e91-e97. Epub 2018 Dec 21.

4 Center for Cancer and Blood Disorders, Fort Worth, TX.

Purpose:: Value-based care infers care that is high quality at a comparatively low total cost. A key strategy for value-based oncology care is to avoid unnecessary emergency room (ER) visits and associated hospitalizations of patients receiving treatment for cancer. Early experience with this strategy showed that symptom management in patients with cancer can result in the reduction of ER events and hospitalizations. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00082DOI Listing
February 2019

CancerLinQ: Cutting the Gordian Knot of Interoperability.

J Oncol Pract 2019 Jan 19;15(1):3-6. Epub 2018 Dec 19.

1 American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00612DOI Listing
January 2019
1 Read

Regionalization of Retroperitoneal Sarcoma Surgery to High-Volume Hospitals: Missed Opportunities for Outcome Improvement.

J Oncol Pract 2018 Dec 14:JOP1800349. Epub 2018 Dec 14.

MedStar-Georgetown Surgical Outcomes Research Center; MedStar-Georgetown University Hospital; Medstar-Washington Hospital Center; Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC; and MedStar Health Research Institute, Hyattsville, MD.

Purpose:: Surgery continues to be the dominant therapy for the management of retroperitoneal soft-tissue sarcoma (RPS). Many groups advocate performing these resections at high-volume hospitals (HVHs), given their complexity. We therefore sought to explore whether RPS surgery has indeed begun to regionalize to HVHs in the same manner as pancreatic cancer (PC) surgery during the last decade. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00349DOI Listing
December 2018
5 Reads

Coordination of Care Around Surgery for Colon Cancer: Insights From National Patterns of Physician Encounters With Medicare Beneficiaries.

J Oncol Pract 2019 Feb 14;15(2):e110-e121. Epub 2018 Dec 14.

3 University of California San Francisco, San Francisco, CA.

Purpose:: To improve care coordination for complex cancers, it is critical to establish a more nuanced understanding of the types of providers involved. As the number of provider types increases, strategies to support cancer care coordination must adapt to a greater variety of information needs, communication styles, and treatment strategies.

Methods:: We categorized providers into 11 types, using National Provider Identifier specialties. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00228DOI Listing
February 2019

Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List.

J Oncol Pract 2019 Feb 14;15(2):e98-e109. Epub 2018 Dec 14.

5 UCLA School of Medicine, Los Angeles, CA.

Purpose:: According to the Institute of Medicine, high-quality cancer care should include effective communication between clinicians and patients about the risks and benefits, expected response, and impact on quality of life of a recommended therapy. In the delivery of oncology care, the barriers to and facilitators of communication about potential long-term and late effects, post-treatment expectations, and transition to survivorship care have not been fully defined.

Patients And Methods:: We collected qualitative data through semistructured interviews with medical oncologists and focus groups with breast cancer survivors and applied the Theoretical Domains Framework to systematically analyze and identify the factors that may influence oncologists' communication with patients with breast cancer about the long-term and late effects of adjuvant therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00162DOI Listing
February 2019
1 Read

Role of Adverse Events in Unscheduled Hospitalizations Among Patients With Solid Tumors Who Receive Medical Oncology Treatment.

J Oncol Pract 2019 Jan 13;15(1):e39-e45. Epub 2018 Dec 13.

1 Dana-Farber Cancer Institute, Boston, MA.

Purpose:: The development of strategies to prevent or mitigate cancer treatment-related adverse events (AEs) is necessary to improve patient experience, safety, and cost containment. To develop a strategy to easily identify and mitigate AEs, we sought to understand the frequency and severity of those that resulted in hospitalizations.

Methods:: We retrospectively characterized hospitalizations of ambulatory adult patients with solid tumor cancers within 30 days of chemotherapy administration using medical record data abstraction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00319DOI Listing
January 2019
1 Read

Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.

J Oncol Pract 2019 Jan 13;15(1):e30-e38. Epub 2018 Dec 13.

1 Memorial Sloan Kettering Cancer Center, New York, NY.

Purpose:: A shift in outpatient oncology care from the physician's office to hospital outpatient settings has generated interest in the effect of practice setting on outcomes. Our objective was to examine whether medical oncologists' prescribing of drugs and services for older adult patients with advanced cancer is used more in physicians' offices compared with hospital outpatient departments.

Methods:: This was a retrospective comparative study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00315DOI Listing
January 2019
1 Read

Advance Care Planning Among Patients With Advanced Cancer.

J Oncol Pract 2019 Jan 13;15(1):e65-e73. Epub 2018 Dec 13.

1 The Pennsylvania State University, College of Medicine, Hershey, PA.

Purpose:: Advance directives (AD) have been heralded as vehicles to promote patient autonomy and have been decried as ineffective. Efforts to improve advance care planning (ACP) and AD documents are wide ranging but have not been prospectively studied.

Materials And Methods:: In an institutional review board-approved, single-blind, randomized, controlled trial, we compared an interactive, educational ACP decision aid to standard ACP among patients with advanced cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00044DOI Listing
January 2019
1 Read

Patient-Centered Medical Homes in Community Oncology Practices: Changes in Spending and Care Quality Associated With the COME HOME Experience.

J Oncol Pract 2019 Jan 5;15(1):e56-e64. Epub 2018 Dec 5.

4 Innovative Oncology Business Solutions, Albuquerque, NM.

Purpose:: We examined whether the Community Oncology Medical Home (COME HOME) program, a medical home program implemented in seven community oncology practices, was associated with changes in spending and care quality.

Patients And Methods:: We compared outcomes from elderly fee-for-service Medicare beneficiaries diagnosed between 2011 and 2015 with breast, lung, colorectal, thyroid, or pancreatic cancer, lymphoma, or melanoma and served by COME HOME practices before and after program implementation versus similar beneficiaries served by other geographically proximate oncologists. Difference-in-differences analysis compared changes in outcomes for COME HOME patients versus concurrent controls. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00479DOI Listing
January 2019
1 Read

Early Clinical and Economic Outcomes of Prophylactic and Acute Pathologic Fracture Treatment.

J Oncol Pract 2019 Feb 4;15(2):e132-e140. Epub 2018 Dec 4.

2 Carolinas Medical Center, Charlotte, NC.

Introduction:: Pathologic fractures often contribute to adverse events in metastatic bone disease, and prophylactic fixation offers to mitigate their effects. This study aims to analyze patient selection, complications, and in-hospital costs that are associated with prophylactic fixation compared with traditional acute fixation after completed fracture.

Materials And Methods:: The Nationwide Inpatient Sample database was queried from 2002 to 2014 for patients with major extremity pathologic fractures. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00431
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00431DOI Listing
February 2019
7 Reads

Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline Summary.

J Oncol Pract 2019 Jan 4;15(1):50-54. Epub 2018 Dec 4.

3 Cedars-Sinai Medical Center, Los Angeles, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00616DOI Listing
January 2019

Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update.

J Oncol Pract 2019 Feb 5;15(2):106-107. Epub 2018 Dec 5.

3 University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00617DOI Listing
February 2019
1 Read

Automating Treatment Summary Development Using Electronic Billing Information: A Pilot Study of Survivors of Head and Neck Cancer.

J Oncol Pract 2019 Jan 3;15(1):e84-e90. Epub 2018 Dec 3.

1 Memorial Sloan-Kettering Cancer Center, New York, NY.

Purpose:: Although the provision of a treatment summary (TS) is a quality indicator in oncology, routine delivery of TSs remains challenging. Automatic TS generation could facilitate use, but data on accuracy are lacking in complex cancers such as head and neck cancer (HNC). We developed and evaluated an electronic platform to automate TS generation for HNC. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333382PMC
January 2019
1 Read

Unplanned Hospitalization Among Individuals With Cancer in the Year After Diagnosis.

J Oncol Pract 2019 Jan 5;15(1):e20-e29. Epub 2018 Dec 5.

2 University of California, Davis, Sacramento, CA.

Purpose:: Reducing acute care use is an important strategy for improving value in cancer care. However, little information is available to describe and compare population-level hospital use across cancer types. Our aim was to estimate unplanned hospitalization rates and to describe the reasons for hospitalization in a population-based cohort recently diagnosed with cancer. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00254
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00254DOI Listing
January 2019
7 Reads

Measuring the Impact of Academic Cancer Network Development on Clinical Integration, Quality of Care, and Patient Satisfaction.

J Oncol Pract 2018 Dec;14(12):e823-e833

Yale New Haven Hospital; Yale School of Medicine; Yale Cancer Center; Smilow Cancer Hospital; and Community Health Educators Group, New Haven, CT.

Purpose:: Many US academic centers have acquired community practices to expand their clinical care and research footprint. The objective of this assessment was to determine whether the acquisition and integration of community oncology practices by Yale/Smilow Cancer Hospital improved outcomes in quality of care, disease team integration, clinical trial accrual, and patient satisfaction at network practice sites.

Methods:: We evaluated quality of care by testing the hypothesis that core Quality Oncology Practice Initiative measures at network sites that were acquired in 2012 were significantly different after their 2016 integration into the network. Read More

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JOP.18.00419
Publisher Site
http://dx.doi.org/10.1200/JOP.18.00419DOI Listing
December 2018
14 Reads

Evaluation of the Measuring and Improving Quality in Palliative Care Survey.

J Oncol Pract 2018 Dec;14(12):e834-e843

Johns Hopkins Bloomberg School of Public Health; Johns Hopkins School of Medicine, Baltimore, MD; University of Cincinnati College of Medicine, Cincinnati, OH; Duke Cancer Institute and Duke Fuqua School of Business, Duke University, Durham, NC; Veterans Affairs Greater Los Angeles Health System, University of California, Los Angeles, Los Angeles; Stanford School of Medicine, Stanford, CA; Temmy Latner Centre for Palliative Care, Sinai Health System; University of Toronto; and Institute for Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada.

Purpose:: To evaluate the reliability, content validity, and variation among sites of a survey to assess facilitators and barriers to quality measurement and improvement in palliative care programs.

Methods:: We surveyed a sample of diverse US and Canadian palliative care programs and conducted postcompletion discussion groups. The survey included constructs addressing educational support and training, communication, teamwork, leadership, and prioritization for quality measurement and improvement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.18.00405DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291741PMC
December 2018